Plaintiffs Awarded $9 Billion in Punitive Damages in Actos Litigation Argue Settlement is Fair, Park

Takeda Pharmaceuticals Co. and Eli Lilly & Co. moving for new trial Port Washington, New York (PRWEB) August 04, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports that the plaintiffs who recently won a $9 billion punitive damages award in the first federal bellwether trial involving Takeda Pharmaceutical’s diabetes medication, Actos, say the verdict should be upheld. According to the plaintiffs, no rule exists that punitive damages must be in, what the National Law Journal described as, a
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations